Endocapillary proliferative glomerulonephritis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Endocapillary proliferative glomerulonephritis | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hematuria, proteinuria, edema, hypertension |
| Complications | Chronic kidney disease, nephrotic syndrome |
| Onset | |
| Duration | |
| Types | N/A |
| Causes | Infection, autoimmune disease |
| Risks | |
| Diagnosis | Urinalysis, renal biopsy |
| Differential diagnosis | IgA nephropathy, post-infectious glomerulonephritis |
| Prevention | N/A |
| Treatment | Corticosteroids, immunosuppressive therapy |
| Medication | |
| Prognosis | Variable, depending on underlying cause |
| Frequency | |
| Deaths | |
Endocapillary proliferative glomerulonephritis is a type of glomerulonephritis characterized by the proliferation of cells within the capillary lumens of the glomerulus. This condition is part of a broader category of kidney diseases that affect the tiny blood vessels in the kidneys responsible for filtering waste from the blood. Endocapillary proliferative glomerulonephritis can lead to hematuria (blood in urine), proteinuria (protein in urine), and various degrees of kidney failure.
Causes[edit]
Endocapillary proliferative glomerulonephritis is often caused by an immune response, where the body's immune system mistakenly attacks the glomeruli. This can be triggered by infections, such as post-streptococcal glomerulonephritis, or by systemic diseases that affect multiple organs and tissues, such as lupus or IgA nephropathy.
Symptoms[edit]
The symptoms of endocapillary proliferative glomerulonephritis can vary widely depending on the severity of the condition. Common symptoms include:
- Hematuria - blood in the urine, which may make the urine appear dark or rusty-colored.
- Proteinuria - excess protein in the urine, which may cause the urine to be foamy.
- Edema - swelling, particularly in the feet, ankles, or face, due to the retention of fluids.
- Hypertension - high blood pressure, as the kidneys' ability to regulate blood pressure is compromised.
Diagnosis[edit]
Diagnosis of endocapillary proliferative glomerulonephritis typically involves a combination of blood tests, urine tests, and imaging studies to assess kidney function and detect the presence of blood and protein in the urine. A definitive diagnosis usually requires a renal biopsy, where a small sample of kidney tissue is examined under a microscope for signs of glomerular inflammation and proliferation.
Treatment[edit]
Treatment for endocapillary proliferative glomerulonephritis focuses on addressing the underlying cause, if known, and managing symptoms. This may include:
- Corticosteroids or other immunosuppressive medications to reduce inflammation and immune system activity.
- Antihypertensive medications to control high blood pressure.
- Diuretics to help remove excess fluid from the body.
- Dietary modifications to reduce strain on the kidneys, such as limiting protein and salt intake.
In severe cases, or if the condition leads to significant kidney damage, dialysis or a kidney transplant may be necessary.
Prognosis[edit]
The prognosis for individuals with endocapillary proliferative glomerulonephritis varies depending on the cause and severity of the condition, as well as the effectiveness of treatment. Early diagnosis and treatment can improve outcomes and may help prevent or delay the progression to chronic kidney disease or kidney failure.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian